Breaking Down Arcus Biosciences: 4 Analysts Share Their Views
Breaking Down Arcus Biosciences: 4 Analysts Share Their Views
解读Arcus Biosciences：4位分析师分享他们的看法
The analysis of recent analyst actions...During the last three months, 4 analysts shared their evaluations of Arcus Biosciences (NYSE:RCUS), revealing diverse outlooks from bullish to bearish.
在过去三个月中，有4名分析师分享了他们对Arcus Biosciences (NYSE:RCUS) 的评价，展现了从看多到看淡的不同态度。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级快照，展示了情绪在过去30天中的演变情况，并将其与之前的月份进行比较。
Analysts have recently evaluated Arcus Biosciences and provided 12-month price targets. The average target is $34.25, accompanied by a high estimate of $44.00 and a low estimate of $25.00. Highlighting a 9.27% decrease, the current average has fallen from the previous average price target of $37.75.
分析师们最近对Arcus Biosciences进行了评估，并提供了12个月的价格目标。平均目标价格为34.25美元，最高目标为44.00美元，最低目标为25.00美元。当前平均目标价格已经下降了9.27%，从之前的37.75美元的平均目标价格下降了。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级：更深入的了解
The analysis of recent analyst actions...
最近分析师行...
登录免费看全文
登录/注册
资讯热榜
更新时间